Machine learning-derived cycle length variability metrics predict spontaneously terminating ventricular tachycardia in implantable cardioverter defibrillator recipients.
Cycle length
Implantable cardioverter defibrillator
Machine learning
Ventricular tachycardia
Journal
European heart journal. Digital health
ISSN: 2634-3916
Titre abrégé: Eur Heart J Digit Health
Pays: England
ID NLM: 101778323
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
received:
03
07
2023
revised:
06
10
2023
accepted:
16
10
2023
medline:
24
1
2024
pubmed:
24
1
2024
entrez:
24
1
2024
Statut:
epublish
Résumé
Implantable cardioverter defibrillator (ICD) therapies have been associated with increased mortality and should be minimized when safe to do so. We hypothesized that machine learning-derived ventricular tachycardia (VT) cycle length (CL) variability metrics could be used to discriminate between sustained and spontaneously terminating VT. In this single-centre retrospective study, we analysed data from 69 VT episodes stored on ICDs from 27 patients (36 spontaneously terminating VT, 33 sustained VT). Several VT CL parameters including heart rate variability metrics were calculated. Additionally, a first order auto-regression model was fitted using the first 10 CLs. Using features derived from the first 10 CLs, a random forest classifier was used to predict VT termination. Sustained VT episodes had more stable CLs. Using data from the first 10 CLs only, there was greater CL variability in the spontaneously terminating episodes (mean of standard deviation of first 10 CLs: 20.1 ± 8.9 vs. 11.5 ± 7.8 ms, Ventricular tachycardia CL variability and instability are associated with spontaneously terminating VT and can be used to predict spontaneous VT termination. Given the harmful effects of unnecessary ICD shocks, this machine learning model could be incorporated into ICD algorithms to defer therapies for episodes of VT that are likely to self-terminate.
Identifiants
pubmed: 38264702
doi: 10.1093/ehjdh/ztad064
pii: ztad064
pmc: PMC10802825
doi:
Types de publication
Journal Article
Langues
eng
Pagination
50-59Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.
Déclaration de conflit d'intérêts
Conflict of interest: A.S., A.A., I.W., and F.S.N. are inventors on a patent application on implantable stimulation devices. D.K. reports Medtronic advisor and speaker honoraria, Z.W. reports Medtronic advisor and speaker honoraria, Abbott steering committee, and Boston Scientific speaker honoraria,